Preferential induction of apoptosis of leukaemic cells by farnesol

FEBS Lett. 2000 Feb 11;467(2-3):291-5. doi: 10.1016/s0014-5793(00)01168-6.

Abstract

Farnesol preferentially inhibits proliferation and induces apoptosis of tumour-derived but not non-transformed cell lines. We investigated whether farnesol induces apoptosis of blasts from patients with acute myeloid leukaemia (AML) and leukaemic cell lines, as compared with normal, human primary haemopoietic cells. We show that 30 microM farnesol causes apoptosis of leukaemic cell lines of T- and B-lymphocyte, myeloid or erythroid lineages and primary blasts obtained from patients with AML. However, the same concentration did not kill primary monocytes, or quiescent or proliferating T-lymphocytes. We conclude that farnesol selectively kills AML blasts and leukaemic cell lines in preference to primary haemopoietic cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Division / drug effects
  • Cell Line, Transformed
  • Farnesol / pharmacology*
  • Humans
  • Jurkat Cells
  • Leukemia, Myeloid, Acute / blood*
  • Monocytes / drug effects*

Substances

  • Farnesol